Rising Biosciences Inc. Acquires SNB Health, Signs Contract to Purchase 40,000 Sq. Ft. Facility for Behavioral Health Addiction Treatment Inpatient Center
June 04, 2019 08:35 ET
|
Rising Biosciences, Inc.
SANDUSKY, Ohio, June 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE — Rising Biosciences, Inc. (OTC: RBII) is pleased to announce the recent acquisition of Southern Northern Behavioral Health, Inc....
Rising Biosciences Inc. Announces New Partnership in Addition to Naming New COO
March 08, 2019 11:23 ET
|
Rising Biosciences, Inc.
SANDUSKY, Ohio, March 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE - - Rising Biosciences Inc. (OTC: RBII), a research development pharmaceutical and physicians practice management company, is...
(CORRECTION) Rising Biosciences Set To Acquire All Assets from PAO Group / Announces Management Change
November 07, 2018 16:07 ET
|
Rising Biosciences, Inc.
SANDUSKY, Ohio, Nov. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Rising Biosciences, Inc. (OTC: RBII) ("RBII" "the Company"), a research and development company focusing on oral and topical...
Rising Biosciences Set To Acquire All Assets from PAO Group
November 07, 2018 15:29 ET
|
Rising Biosciences, Inc.
SANDUSKY, Ohio, Nov. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Rising Biosciences, Inc. (OTC : RBII) ("RBII" "the Company"), a research and development company focusing on oral and topical...
Rising Biosciences Receives FDA Clearance for TSW Pain Cream; Expedites Testing of CBD Only Variants of Cannophen™ and TSW Pain Cream Products
October 10, 2018 08:30 ET
|
Rising Biosciences, Inc.
RBII Seeks Corporate Registration in Canada Alongside Country’s Decision to Legalize Marijuana SANDUSKY, Ohio, Oct. 10, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Rising Biosciences, Inc. (RBII)...
Rising Biosciences Launches RBS0346 Clinical Strength Dulcis Stem Cell Cream on Amazon; Advancements in FDA Approvals Indicate Bright Future for Cannophen™
July 02, 2018 11:00 ET
|
Rising Biosciences, Inc.
SANDUSKY, Ohio, July 02, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Rising Biosciences, Inc. (RBII) (“RBII” “the Company”), a research and development company focusing on oral and topical...
Rising Biosciences Anticipates Products on MMJ Dispensary Shelves in Late September 2018
June 11, 2018 13:24 ET
|
Rising Biosciences, Inc.
RBII to Contract with Producers/Processors in MMJ States to License and Market Cannophen™, THC Products SANDUSKY, Ohio, June 11, 2018 (GLOBE NEWSWIRE) -- (via OTC PR WIRE) – Rising...
Rising Biosciences Announces Official Sales and Distribution of its RSB0238 Clinical Strength Peptide Complex on Amazon®
May 01, 2018 13:26 ET
|
Rising India, Inc.
RSII’s serum ranks among top best-sellers in its category SANDUSKY, Ohio, May 01, 2018 (GLOBE NEWSWIRE) -- (via OTC PR WIRE) -- Rising India, Inc.'s Rising Biosciences (OTC:RSII) (“RSII” “the...
Rising Biosciences Expedites Growth/Expansion with In-House Chemist, Laboratory Analytical Equipment and Producer/Processor Contracts
March 20, 2018 11:53 ET
|
Rising India, Inc.
SANDUSKY, Ohio, March 20, 2018 (GLOBE NEWSWIRE) -- (via OTC PR WIRE) --Rising India, Inc.’s (OTC:RSII) -- Rising Biosciences, Inc., a research and development company focusing on oral and topical...
Rising Biosciences, Inc. To Offer Cannophen™ to Patients in Ohio, Florida; Launches Initiatives for National Distribution of Scar Peptide Serum
February 20, 2018 09:45 ET
|
Rising India, Inc.
SANDUSKY, Ohio, Feb. 20, 2018 (GLOBE NEWSWIRE) -- (via OTC PR WIRE) -- Rising India, Inc.’s (OTC:RSII) -- Rising Biosciences, Inc., a research and development company focusing on oral and topical...